Philips sees 1%-3% growth in 2025 comparable sales
FILE PHOTO: Dutch technology company Philips' logo is seen at company headquarters in Amsterdam, Netherlands, January 29, 2019. REUTERS/Eva Plevier/File Photo
(Reuters) -Dutch healthcare technology company Philips forecast a growth of 1% to 3% in 2025 comparable sales on Wednesday after missing market expectations for the final quarter of last year partly due to a double-digit decline in China.
The forecast includes a mid- to high-single-digit decline in China sales and the impact of recently announced tariffs by the U.S. and China, the group said in a statement.
Total sales came in at 5.04 billion euros ($5.27 billion) for the quarter ended December. Analysts, on average, had forecast sales of 5.07 billion euros, according to a poll provided by Philips.
The group, which sells products ranging from toothbrushes to medical imaging systems, had cut its 2024 sales forecast in October, following a significant slump in China demand in the third quarter.
Group CEO Roy Jakobs said in January he expected China to account for around 10% of revenues, down from over 13% earlier in the decade.
Philips employs more than 7,000 people in the country.
The group said its adjusted earnings before interest, tax, and amortisation (EBITA) came in at 679 million euros for the December quarter, slightly below the 683 million euros analysts had expected.
The company proposed an annual dividend of 0.85 euros per share, in line with the dividend it paid out for 2023.
($1 = 0.9562 euros)
(Reporting by Alessandro Parodi in Gdansk; Editing by Subhranshu Sahu)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- ThinkEquity Starts Deep Isolation Nuclear (DBHL) at Buy
- Genco rejects Diana Shipping takeover bid as undervalued
Create E-mail Alert Related Categories
ReutersRelated Entities
Dividend, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share